BDBM332052 US10196353, Example 2::US11299457, Example 2

SMILES CCC(C(=O)OC)n1c(C)cc2c(c(ccc12)C#N)C(F)(F)F

InChI Key InChIKey=BJNAVMMYORPBLT-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 332052   

TargetProgesterone receptor(Human)
Glaxosmithkline

US Patent
LigandPNGBDBM332052(US10196353, Example 2 | US11299457, Example 2)
Affinity DataIC50: 100nMAssay Description:Compounds are added to the 384 well black low-volume plates to a final volume of 0.1 μL. DTT and DMSO are added to the chilled assay buffer just...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332052(US10196353, Example 2 | US11299457, Example 2)
Affinity DataIC50: 100nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent